S. Burli

Learn More
Osteoporosis is a metabolic bone disease, characterized by increased porosity of the skeleton resulting from reduced bone mass, the associated structural changes predispose the bone to fracture. The drug discovery process in this direction is very attractive, because of non-availability of suitable, safe and effective means for the management of this(More)
  • 1